Thymic Carcinoma

• CLINICAL_TRIALS research · 2026-04-24
  Clinical Trial Update: A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy [Phase 2]

  This update describes a Phase 2 pilot study assessing the safety and clinical activity of Avelumab in patients with thymoma or thymic carcin…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma [Phase 2]

  This report provides an update on a Phase 2 clinical trial of bintrafusp alfa (M7824) in patients with thymic epithelial tumors, thymoma, an…

• CLINICAL_TRIALS research · 2026-04-01
  Clinical Trial Update: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection [NA]

  Clinical trial update on adjuvant hypofractionation radiotherapy after complete resection of thymic epithelial tumors, with the trial curren…

• CLINICAL_TRIALS research · 2026-03-11
  Clinical Trial Update: 6 vs 3 Cycles of Neoadjuvant Chemotherapy for Potentially Resectable Locally Advanced Thymic Epithelial Tumors [Phase 2, Phase 3]

  A Phase 2/Phase 3 clinical trial is evaluating whether six cycles of neoadjuvant chemotherapy provide different outcomes than three cycles f…

• CLINICAL_TRIALS research · 2026-03-11
  Clinical Trial Update: HEARTS Trial for Thoracic Cancers [Phase 2]

  HEARTS is a Phase 2 clinical trial targeting thoracic cancers, including non-small cell lung cancer, esophageal cancer, esophagogastric canc…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2026-02-05
  Clinical Trial Update: Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis

  A clinical trial from Shanghai General Hospital evaluates electrocautery resection with hyperthermic intrathoracic chemotherapy (HITHOC) for…

• CLINICAL_TRIALS research · 2026-01-30
  Clinical Trial Update: Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer [Phase 1]

  A phase 1 trial evaluating pembrolizumab for unresectable thymoma or thymic carcinoma is currently recruiting.

• CLINICAL_TRIALS research · 2026-01-27
  Clinical Trial Update: A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors [Phase 2]

  Phase II trial investigating sacituzumab govitecan in advanced thymic epithelial tumors is currently recruiting.

• CLINICAL_TRIALS research · 2026-01-09
  Clinical Trial Update: Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma [Phase 2]

  A Phase 2 clinical trial evaluating Sacituzumab Tirumotecan in locally advanced or metastatic thymic carcinoma; the study is not yet recruit…

• CLINICAL_TRIALS research · 2025-12-26
  Clinical Trial Update: Molecular Analysis of Thoracic Malignancies

  This clinical trial update describes ongoing molecular analyses of thoracic malignancies, including thymic tumors and thoracic carcinomas, w…

• CLINICAL_TRIALS research · 2025-10-20
  Clinical Trial Update: Ivonescimab for the Treatment of Thymic Cancer [Phase 2]

  A Phase 2 clinical trial evaluating Ivonescimab for thymic carcinoma is currently recruiting.

• CLINICAL_TRIALS research · 2025-10-02
  Clinical Trial Update: CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors [Phase 1]

  A Phase 1 clinical trial of a CD70-targeted CAR-T therapy for CD70-positive advanced solid tumors is currently recruiting, enrolling patient…

• CLINICAL_TRIALS research · 2025-09-08
  Clinical Trial Update: Characterisation of the Immune Infiltrate and Molecular Features of Thymic Epithelial Tumors Tumors (TETs) (IMMUNO-TET) [NA]

  A clinical trial led by Institut Curie to characterize the immune infiltrate and molecular features of thymic epithelial tumors (thymomas an…

• CLINICAL_TRIALS research · 2025-07-04
  Clinical Trial Update: A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest [Phase 2]

  A Phase 2 clinical trial evaluating intensity-modulated pleural radiation therapy (IMPRINT) for thymic malignancies with pleural metastases;…

• CLINICAL_TRIALS research · 2025-06-13
  Clinical Trial Update: Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors [Phase 2]

  A Phase 2 clinical study evaluating carbon ion radiotherapy combined with chemotherapy for thymic epithelial tumors (thymoma and thymic carc…

• CLINICAL_TRIALS research · 2025-06-13
  Clinical Trial Update: The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor [Phase 2]

  A Phase 2 clinical trial evaluating postoperative proton radiotherapy for thymic epithelial tumors is currently recruiting.

• CLINICAL_TRIALS research · 2025-05-22
  Clinical Trial Update: Molecular Analysis and Treatment Options of Thymic Malignancies

  A Shanghai chest hospital trial is currently recruiting to analyze molecular features and explore treatment options for thymic epithelial tu…

• CLINICAL_TRIALS research · 2024-11-18
  Clinical Trial Update: Hypofractionated Radiotherapy for Thymic Epithelial Tumors [NA]

  An ongoing clinical trial evaluating hypofractionated radiotherapy for thymic epithelial tumors, including thymoma and thymic carcinoma; rec…

• CLINICAL_TRIALS research · 2024-05-10
  Clinical Trial Update: Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) [Phase 3]

  A Phase 3 clinical trial conducted by Fudan University (FUSCC-Thymic 3) is evaluating postoperative adjuvant chemotherapy for thymic carcino…